Blackstone agrees to buy Ancestry in $4.7 billion deal
The investment firm Blackstone is scooping up a majority stake in the direct-to-consumer genetics company Ancestry for $4.7 billion.
Read The StoryHealth Tech
Tracking how tech is transforming health care and the life sciences. To get the latest delivered to your inbox, sign up for our free STAT Health Tech newsletter. And subscribe to STAT Plus for exclusive analysis of the interlopers and technologies disrupting health care.
Teladoc Health reaches agreement to buy Livongo in a $18.5 billion deal
Haven was supposed to reimagine health care. An exodus of talent has gutted it
10 burning questions about Teladoc’s $18.5 billion deal to buy Livongo
Telemedicine is booming — but many people still face huge barriers to virtual care
All Coverage
advertisement
